Table 2 Treatment related adverse events
Adverse event, n (%) | Any grade | Grade 1 | Grade 2 | Grade 3 | Grade 4 | Grade 5 |
|---|---|---|---|---|---|---|
Pneumonitis | 17 (70.8) | 8 (33.3) | 5 (20.8) | 3 (12.5) | 0 | 1 (4.2) |
 RP | 9 (37.5) | 5 (20.8) | 1 (4.2) | 2 (8.3) | 0 | 1 (4.2) |
 CIP | 8 (33.3) | 3 (12.5) | 4 (16.6) | 1 (4.2) | 0 | 0 |
Leukopenia | 17 (70.8) | 10 (41.7) | 4 (16.7) | 2 (8.3) | 1 (4.2) | 0 |
Anemia | 11 (45.8) | 9 (37.5) | 2 (8.3) | 0 | 0 | 0 |
Thrombocytopenia | 10 (41.7) | 9 (37.5) | 1 (4.2) | 0 | 0 | 0 |
Esophagitis | 15 (62.5) | 5 (20.8) | 10 (41.6) | 0 | 0 | 0 |
Radiation dermatitis | 4 (16.7) | 4 (16.7) | 0 | 0 | 0 | 0 |
Fatigue | 6 (25.0) | 5 (20.8) | 1 (4.2) | 0 | 0 | 0 |
Pyrexia | 3 (12.5) | 3 (12.5) | 0 | 0 | 0 | 0 |
Elevated ALT | 4 (16.7) | 3 (12.5) | 1 (4.2) | 0 | 0 | 0 |
Nausea | 5 (20.8) | 5 (20.8) | 0 | 0 | 0 | 0 |
Diarrhea | 2 (8.3) | 2 (8.3) | 0 | 0 | 0 | 0 |
Pruritus | 2 (8.3) | 2 (8.3) | 0 | 0 | 0 | 0 |
Rash | 3 (12.5) | 3 (12.5) | 0 | 0 | 0 | 0 |
Thyroid dysfunction | 3 (12.5) | 3 (12.5) | 0 | 0 | 0 | 0 |
Musculoskeletal pain | 1 (4.2) | 1 (4.2) | 0 | 0 | 0 | 0 |
Cough | 1 (4.2) | 1 (4.2) | 0 | 0 | 0 | 0 |
Peripheral neuropathy | 1 (4.2) | 1 (4.2) | 0 | 0 | 0 | 0 |
Adrenal insufficiency | 1 (4.2) | 1 (4.2) | 0 | 0 | 0 | 0 |